Eletriptan Hydrobromide Tablet, Film Coated
Product Images NDC 63629-8320

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 63629-8320). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Eletriptan Fig1)

A line chart showing estimated probability of response over time in hours from initial dose, comparing double blind placebo and Eletriptan at 20 mg, 40 mg, and 80 mg doses. The y-axis measures estimated probability of response, and the x-axis represents time up to 2 hours.*

FDA Label Image

Figure2 (Eletriptan Fig2)

A line graph showing the probability of second dose or other medication use over 24 hours following the initial dose. The graph compares responses for double blind placebo, Eletriptan Hydrobromide 20 mg, 40 mg, and 80 mg doses, with probability increasing over time for each group.*

FDA Label Image

Chemical Structure (Eletriptan Str)

Chemical structure of Eletriptan Hydrobromide, showing its molecular framework including aromatic rings, a sulfonyl group, and a methylated pyrrolidine moiety with the hydrobromide salt indicated.*

FDA Label Image

Label (Lbl636298320)

Eletriptan Hydrobromide 40 mg film-coated tablet packaging label. The label indicates packaging by Bryant Ranch Prepack in Burbank, CA. It compares to Relpax 40 mg tablet blister pack by Aurobindo Pharma Limited. Includes storage instructions to keep at 20°-25°C (68°-77°F) and a warning to keep all drugs out of reach of children. The label also shows an NDC number 63629-8320-1 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.